Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Catherine Liu(University of California, San Francisco), Arnold S. Bayer(University of California, Los Angeles), Sara E. Cosgrove(Johns Hopkins University), Robert S. Daum(University of Chicago), Scott K. Fridkin(Centers for Disease Control and Prevention), Rachel Gorwitz(Centers for Disease Control and Prevention), Sheldon L. Kaplan(Baylor College of Medicine), Adolf W. Karchmer(Beth Israel Deaconess Medical Center), Donald P. Levine(Wayne State University), Barbara E. Murray(Texas Center for Infectious Disease), Michael J. Rybak(Wayne State University), David A. Talan(University of California, Los Angeles), Henry F. Chambers(San Francisco General Hospital)
Clinical Infectious Diseases
January 6, 2011
10.1093/cid/ciq146
Cited by 4,165Open Access
Full Text

Abstract

Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.

Related Papers

No related papers found

Powered by citation graph analysis